Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2020 Filed Jun 9, 2020 16:17 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001562180-20-004359 · primarydocument.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2030-06-05 F3 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 16:17 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004359 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,431 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:17 UTC |
Enyedy Mark JDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001562180-20-004355 · primarydocument.xml · derivative · entry 2 Enyedy Mark J · CIK 0001586965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2030-06-05 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:17 UTC |
Enyedy Mark JDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004355 · primarydocument.xml · nonDerivative · entry 1 Enyedy Mark J · CIK 0001586965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,143 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:17 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001562180-20-004360 · primarydocument.xml · derivative · entry 3 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2030-06-05 F3 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:17 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004360 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,400 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:34 UTC | SaleCommon Stock | 6,426 | $11.58 | $74,413.08 |
DisclosureSEC source: 0001562180-20-004068 · primarydocument.xml · nonDerivative · entry 1 Faulkingham Dell · CIK 0001776024 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,574 F1 · shares: This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 31, 2019. Read SEC document |
|
| April 06, 2020 Filed Apr 7, 2020 12:31 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 80,200 | $0.00 Strike: $7.09 | $0.00 |
DisclosureSEC source: 0001562180-20-002937 · primarydocument.xml · derivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,200 Underlying: Common Stock · 80,200 shares Expires 2030-04-06 F1 · derivative.exercise_date: The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:29 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantStock Option (Right to buy) · Derivative | 120,000 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001937 · primarydocument.xml · derivative · entry 3 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-02-28 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:29 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 6,972 | $8.70 | $60,656.40 |
DisclosureSEC source: 0001562180-20-001937 · primarydocument.xml · nonDerivative · entry 2 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,960 F2 · shares: This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:29 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001937 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,932 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:27 UTC |
Amello JasonSVP, CFO & Treasurer
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001935 · primarydocument.xml · derivative · entry 3 Amello Jason · CIK 0001451805 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-02-28 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:27 UTC |
Amello JasonSVP, CFO & Treasurer
|
SaleCommon Stock | 6,976 | $8.70 | $60,691.20 |
DisclosureSEC source: 0001562180-20-001935 · primarydocument.xml · nonDerivative · entry 2 Amello Jason · CIK 0001451805 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,642 F3 · shares: This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:27 UTC |
Amello JasonSVP, CFO & Treasurer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001935 · primarydocument.xml · nonDerivative · entry 1 Amello Jason · CIK 0001451805 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,618 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2019 and 1,500 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:28 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantStock Option (Right to buy) · Derivative | 105,000 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001936 · primarydocument.xml · derivative · entry 3 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2030-02-28 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:28 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 7,050 | $8.70 | $61,335.00 |
DisclosureSEC source: 0001562180-20-001936 · primarydocument.xml · nonDerivative · entry 2 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,756 F3 · shares: This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:28 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantCommon Stock | 62,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001936 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,806 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2019 and 1,500 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:26 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
GrantStock Option (Right to buy) · Derivative | 85,000 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001934 · primarydocument.xml · derivative · entry 3 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-02-28 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:26 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
SaleCommon Stock | 3,454 | $8.70 | $30,049.80 |
DisclosureSEC source: 0001562180-20-001934 · primarydocument.xml · nonDerivative · entry 2 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,679 F3 · shares: This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:26 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001934 · primarydocument.xml · nonDerivative · entry 1 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,133 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. F2 · balance_after: Includes 1,364 shares of the Issuer's common stock purchased on June 28, 2019 and 1,445 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:26 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 403,600 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001931 · primarydocument.xml · derivative · entry 8 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,600 Underlying: Common Stock · 403,600 shares Expires 2030-02-28 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:26 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 237,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001931 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,632 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:25 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 105,500 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001930 · primarydocument.xml · derivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,500 Underlying: Common Stock · 105,500 shares Expires 2030-02-28 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:25 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 62,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001930 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:25 UTC | GrantStock Option (Right to buy) · Derivative | 94,000 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001562180-20-001929 · primarydocument.xml · derivative · entry 2 Faulkingham Dell · CIK 0001776024 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,000 Underlying: Common Stock · 94,000 shares Expires 2030-02-28 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
|
| February 28, 2020 Filed Mar 3, 2020 00:25 UTC | GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001929 · primarydocument.xml · nonDerivative · entry 1 Faulkingham Dell · CIK 0001776024 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
|
| November 20, 2019 Filed Nov 21, 2019 11:31 UTC |
ADAMS ADRIANDirector
|
PurchaseCommon Stock | 50,000 | $3.41 | $170,500.00 |
DisclosureSEC source: 0001562180-19-005622 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,700 F1 · kind: The purchase reported in this Form 4 was made on the open market. F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.37 to $3.44, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| November 20, 2019 Filed Nov 21, 2019 11:32 UTC |
Butler John P.Director · CEO and President
|
PurchaseCommon Stock | 50,000 | $3.44 | $172,000.00 |
DisclosureSEC source: 0001562180-19-005623 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,732 F1 · kind: The purchase reported in this Form 4 was made on the open market. F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.65, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. F3 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 06:20 UTC |
GILMAN STEVEN CDirector
|
PurchaseCommon Stock | 5,800 | $3.43 | $19,894.00 |
DisclosureSEC source: 0001562180-19-005642 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,731 F1 · kind: The purchase reported in this Form 4 was made on the open market. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 11:20 UTC |
Smith CynthiaDirector
|
PurchaseCommon Stock | 15,000 | $3.52 | $52,800.00 |
DisclosureSEC source: 0001562180-19-005641 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 F1 · kind: The purchase reported in this Form 4 was made on the open market. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 11:19 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
PurchaseCommon Stock | 27,000 | $3.58 | $96,660.00 |
DisclosureSEC source: 0001562180-19-005640 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 F1 · kind: The purchase reported in this Form 4 was made on the open market. F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.64, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 20:03 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to buy) · Derivative | 250,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001562180-19-004618 · primarydocument.xml · derivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-08-30 F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 20:03 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-004618 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Morrison Jodie PopeDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003438 · primarydocument.xml · derivative · entry 2 Morrison Jodie Pope · CIK 0001618247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Morrison Jodie PopeDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003438 · primarydocument.xml · nonDerivative · entry 1 Morrison Jodie Pope · CIK 0001618247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,619 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Heffernan Michael ThomasDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003437 · primarydocument.xml · derivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Heffernan Michael ThomasDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003437 · primarydocument.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,186 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
GOWEN MAXINEDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003436 · primarydocument.xml · derivative · entry 2 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
GOWEN MAXINEDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003436 · primarydocument.xml · nonDerivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:03 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003432 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:03 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003432 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003439 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003439 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,929 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:03 UTC |
Canute Scott ADirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003433 · primarydocument.xml · derivative · entry 2 Canute Scott A · CIK 0001303416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:03 UTC |
Canute Scott ADirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003433 · primarydocument.xml · nonDerivative · entry 1 Canute Scott A · CIK 0001303416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:04 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003435 · primarydocument.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:04 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003435 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,931 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003440 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003440 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:04 UTC |
Enyedy Mark JDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-19-003434 · primarydocument.xml · derivative · entry 2 Enyedy Mark J · CIK 0001586965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2029-06-06 F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.